Compare Abbott Laboratories (ABT) vs Arista Networks Inc (ANET) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Abbott Laboratories vs Arista Networks Inc — how do they compare? Abbott Laboratories trades at $95.61 (market cap $166.94B), while Arista Networks Inc trades at $176.5 (market cap $209.60B). The key difference: Arista Networks Inc is the larger of the two by market cap, and Abbott Laboratories pays a 2.63% dividend while Arista Networks Inc pays none. Which is the better fit depends on your goals.
| ABT | ANET | |
|---|---|---|
Market Cap | $166.94B | $209.60B |
Sector | Health | Technology |
52-Week High | $136.62 | $177.73 |
52-Week Low | $82.57 | $103.39 |
Enterprise Value | $193.69B | $197.25B |
Dividend Yield | 2.63% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Abbott Laboratories (ABT) trades at $95.63, up 0.25% on the day, with a bullish technical signal from moving averages and strong analyst support. The stock shows solid fundamentals with a P/E of 26.79 and net income margin of 13.91%, though recent earnings have been mixed. Recent news highlights regulatory approvals for new medical devices, supporting growth prospects.
The outlook remains positive with a consensus price target of $122.55, implying significant upside. Key risks include competitive pressures and macroeconomic headwinds, but strong institutional backing and consistent dividend payments provide stability for long-term investors.
Arista Networks (ANET) trades at $166.46, up 4.04% in the last session, with a bullish technical outlook and strong fundamental performance. The company reported revenue of $9.01B in 2025, with net income of $3.51B and a net margin of 38.32%. Recent quarters show consistent earnings beats, and analyst consensus is strongly bullish with a $192.82 price target. Technical indicators suggest the stock is near key resistance at $171, with support at $164.
ANET presents a compelling growth opportunity driven by AI networking demand and robust financials, but elevated valuation ratios (P/E 59.55) and competitive pressures pose risks. The stock's upside is supported by analyst optimism and institutional interest, though investors should monitor execution risks and market volatility.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Abbott Laboratories
Abbott manufactures and markets medical devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, molecular diagnostic platforms, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.
Read more on ABT →About Arista Networks Inc
Arista Networks is a software and hardware provider for the networking solutions sector. Operating as one business unit, software, switching, and router products are targeted for high-performance networking applications, while service revenue comes from technical support. Customer markets include data centers, enterprises, service providers, and campuses. The company is headquartered in Santa Clara, California, and generates most of its revenue in the Americas.
Read more on ANET →
